Obesity is the fastest-growing cause of disease and death in America. Seeking diet components that can reduce energy intake becomes an attractive approach to prevent overweight and obesity. Resistant starch is a dietary carbohydrate that resists digestion in the small intestine and is fermented in the large intestine. Our preliminary studies revealed that feeding resistant starch significantly altered energy balance and decreased body fat in rodents. Additionally, resistant starch fed rodents had higher gene expressions for peptide YY (PYY) and proglucagon (a precursor of glucagon-like peptide-1, GLP-1) in the gut, and higher serum levels of PYY and GLP-1 when compared to controls. PYY and GLP-1 are satiety peptides. Administration of either PYY or GLP-1 reduces food intake. Thus, we hypothesize that the decreased body fat is due to increased PYY and/or GLP-1 (PYY/GLP-1) in resistant starch fed animals. The hypothesis will be tested in three specific aims.
Specific Aim 1 : Determine if PYY and GLP- 1 receptors are required for resistant starch to decrease body fat. This will be achieved by blocking PYY/GLP-1 action through PYY/GLP-1 receptor antagonists or by knocking out of the PYY/GLP-1 receptors.
Specific Aim 2 : Determine if PYY/GLP-1 decrease body fat via visceral nerves or the brain. The peripheral sites of action for PYY/GLP-1 will be tested by destroying visceral afferent neurons to block signals to the brain.
Specific Aim 3 : Determine if resistant starch decreases body fat in robust obese animal models. A diet-induced obesity model and a genetic obese model will be used to see if resistant starch can prevent obesity. These experiments will reveal that PYY and GLP-1 are part of the mechanism of resistant starch on reducing body fat. Thus, a simple dietary intervention can increase levels of these peptides and reduce body fat naturally without surgery or pharmaceutical means. The uniqueness of this project is that we will examine nutrient-gene interactions to test a novel concept of diet composition and energy balance. This dietary approach is potentially of great therapeutic importance in the prevention of human obesity. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21DK073403-02
Application #
7282680
Study Section
Integrative Physiology of Obesity and Diabetes Study Section (IPOD)
Program Officer
Yanovski, Susan Z
Project Start
2006-08-15
Project End
2009-05-31
Budget Start
2007-06-01
Budget End
2009-05-31
Support Year
2
Fiscal Year
2007
Total Cost
$178,421
Indirect Cost
Name
Lsu Pennington Biomedical Research Center
Department
Type
Organized Research Units
DUNS #
611012324
City
Baton Rouge
State
LA
Country
United States
Zip Code
70808
Zhou, June; Martin, Roy J; Raggio, Anne M et al. (2015) The importance of GLP-1 and PYY in resistant starch's effect on body fat in mice. Mol Nutr Food Res 59:1000-3
Keenan, Michael J; Zhou, June; Hegsted, Maren et al. (2015) Role of resistant starch in improving gut health, adiposity, and insulin resistance. Adv Nutr 6:198-205
Vidrine, Kirk; Ye, Jianping; Martin, Roy J et al. (2014) Resistant starch from high amylose maize (HAM-RS2) and dietary butyrate reduce abdominal fat by a different apparent mechanism. Obesity (Silver Spring) 22:344-8
Charrier, Jason A; Martin, Roy J; McCutcheon, Kathleen L et al. (2013) High fat diet partially attenuates fermentation responses in rats fed resistant starch from high-amylose maize. Obesity (Silver Spring) 21:2350-5
Zhou, June; Keenan, Michael J; Fernandez-Kim, Sun Ok et al. (2013) Dietary resistant starch improves selected brain and behavioral functions in adult and aged rodents. Mol Nutr Food Res 57:2071-4
Zhou, June; Keenan, Michael J; Keller, Jeffrey et al. (2012) Tolerance, fermentation, and cytokine expression in healthy aged male C57BL/6J mice fed resistant starch. Mol Nutr Food Res 56:515-8
Shen, Li; Keenan, Michael J; Martin, Roy J et al. (2009) Dietary resistant starch increases hypothalamic POMC expression in rats. Obesity (Silver Spring) 17:40-5
Zhou, June; Martin, Roy J; Tulley, Richard T et al. (2009) Failure to ferment dietary resistant starch in specific mouse models of obesity results in no body fat loss. J Agric Food Chem 57:8844-51
Zhou, June; Martin, Roy J; Tulley, Richard T et al. (2008) Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents. Am J Physiol Endocrinol Metab 295:E1160-6